Management of ventricular tachycardias: insights on centre settings, procedural workflow, endpoints, and implementation of guidelines-results from an EHRA survey
- PMID: 38363995
- PMCID: PMC10872712
- DOI: 10.1093/europace/euae030
Management of ventricular tachycardias: insights on centre settings, procedural workflow, endpoints, and implementation of guidelines-results from an EHRA survey
Abstract
Ventricular tachycardia (VT), and its occurrence, is still one of the main reasons for sudden cardiac death and, therefore, for increased mortality and morbidity foremost in patients with structural heart [Kahle A-K, Jungen C, Alken F-A, Scherschel K, Willems S, Pürerfellner H et al. Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium. Europace 2022;24:538-51]. Catheter ablation has become a safe and effective treatment option in patients with recurrent VT [Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm 2020;17:e2-154]. Previous and current guidelines provide guidance on indication for VT ablation and risk assessment and evaluation of underlying disease. However, no uniform recommendation is provided regarding procedural strategies, timing of ablation, and centre setting. Therefore, these specifics seem to differ largely, and recent data are sparse. This physician-based European Heart Rhythm Association survey aims to deliver insights on not only infrastructural settings but also procedural specifics, applied technologies, ablation strategies, and procedural endpoints. Therefore, these findings might deliver a real-world scenario of VT management and potentially are of guidance for other centres.
Keywords: Advanced ablation; Guidelines; Medical therapy; Sudden cardiac death; VT ablation.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: I have read the journal’s policy, and the authors of this manuscript have the following competing interests: A.S. has received speaker honoraria and consulting fees from Abbott, Boston Scientific, J&J, and Medtronic. L.R. has received speaker honoraria from Abbott and consulting honoraria from Medtronic. He also has received a research grant to the institution from Medtronic. All remaining authors declare that no competing interests exist.
Figures
![Graphical Abstract](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a5/10872712/6f0cbfe5bf7c/euae030_ga1.gif)
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a5/10872712/7250543cc501/euae030f1.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a5/10872712/687896cbdde1/euae030f2.gif)
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a5/10872712/c8f1c9e98741/euae030f3.gif)
![Figure 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a5/10872712/26328276509d/euae030f4.gif)
![Figure 5](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a5/10872712/49b6b66e81c7/euae030f5.gif)
![Figure 6](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a5/10872712/070796e3042f/euae030f6.gif)
Similar articles
-
Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association Survey.Europace. 2018 Jan 1;20(1):209-213. doi: 10.1093/europace/eux332. Europace. 2018. PMID: 29186419
-
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.Europace. 2019 Aug 1;21(8):1143-1144. doi: 10.1093/europace/euz132. Europace. 2019. PMID: 31075787 Free PMC article.
-
A Prospective, Multicentre Randomised Controlled Trial Comparing Catheter Ablation Versus Antiarrhythmic Drugs in Patients With Structural Heart Disease Related Ventricular Tachycardia: The CAAD-VT Trial Protocol.Heart Lung Circ. 2023 Feb;32(2):184-196. doi: 10.1016/j.hlc.2022.09.006. Epub 2023 Jan 2. Heart Lung Circ. 2023. PMID: 36599791
-
Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.J Interv Card Electrophysiol. 2016 Mar;45(2):111-7. doi: 10.1007/s10840-015-0083-4. Epub 2015 Dec 22. J Interv Card Electrophysiol. 2016. PMID: 26695501 Review.
-
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary.Heart Rhythm. 2020 Jan;17(1):e155-e205. doi: 10.1016/j.hrthm.2019.03.014. Epub 2019 May 10. Heart Rhythm. 2020. PMID: 31102616 Free PMC article. Review.
Cited by
-
Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network.Europace. 2024 Oct 3;26(10):euae248. doi: 10.1093/europace/euae248. Europace. 2024. PMID: 39331050 Free PMC article.
-
Optimizing ventricular tachycardia ablation through imaging-based assessment of arrhythmic substrate: A comprehensive review and roadmap for the future.Heart Rhythm O2. 2024 Jul 5;5(8):561-572. doi: 10.1016/j.hroo.2024.07.001. eCollection 2024 Aug. Heart Rhythm O2. 2024. PMID: 39263615 Free PMC article. Review.
-
Acute post-procedural inducibility is a poor predictor of clinical outcomes in high-risk patients (PAINESD > 17) undergoing scar-related ventricular tachycardia ablation.Europace. 2024 Jul 2;26(7):euae185. doi: 10.1093/europace/euae185. Europace. 2024. PMID: 39031021 Free PMC article.
-
Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion.Europace. 2024 May 2;26(5):euae109. doi: 10.1093/europace/euae109. Europace. 2024. PMID: 38657209 Free PMC article. Clinical Trial.
-
Safety and efficacy of same-day discharge for premature ventricular complex ablations.Europace. 2024 Aug 3;26(8):euae205. doi: 10.1093/europace/euae205. Europace. 2024. PMID: 39087957 Free PMC article.
References
-
- Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NAet al. . 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997–4126 . - PubMed
-
- Lynge TH, Risgaard B, Banner J, Nielsen JL, Jespersen T, Stampe NKet al. . Nationwide burden of sudden cardiac death: a study of 54,028 deaths in Denmark. Heart Rhythm 2021;18:1657–65. - PubMed
-
- Kahle A-K, Jungen C, Alken F-A, Scherschel K, Willems S, Pürerfellner Het al. . Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium. Europace 2022;24:538–51. - PubMed